Abingdon Health Income Statement

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	9.57	8.43	6.14	4.05	2.84	11.62
Revenue Growth (YoY)	40.37%	37.39%	51.67%	42.68%	-75.60%	121.93%
Cost of Revenue	5.61	4.69	2.46	1.97	6.43	7.48
Gross Profit	3.96	3.74	3.68	2.08	-3.59	4.14
Selling, General & Admin	7.88	7.71	5.31	5.22	6.65	7.55
Amortization of Goodwill & Intangibles	0.11	0.11	0.03	0.03	0.12	0.04
Other Operating Expenses	-0.76	-0.47	-0.26	-0.25	-0.24	-0.15
Operating Expenses	7.93	8.07	5.53	5.69	8.27	9.52
Operating Income	-3.97	-4.33	-1.85	-3.61	-11.87	-5.37
Interest Expense	-0.06	-0.07	-0.05	-0.07	-0.07	-0.23
Interest & Investment Income	0.07	0.1	0.03	0.09	0	-
Other Non Operating Income (Expenses)	0.44	0.44	0.24	0.39	-	-
EBT Excluding Unusual Items	-3.53	-3.86	-1.63	-3.21	-11.93	-5.61
Merger & Restructuring Charges	-	-	-0.11	-0.16	-0.2	-0.19
Impairment of Goodwill	-	-	-	-	-0.76	-
Gain (Loss) on Sale of Investments	0.01	0.01	-	-	-	-
Asset Writedown	0.14	0.14	-	-0.09	-6.43	-
Legal Settlements	-	-	-	-	-1.59	-
Other Unusual Items	0.21	0.21	0.34	-0.12	-0.69	-1.16
Pretax Income	-3.16	-3.5	-1.4	-3.57	-21.59	-6.95
Income Tax Expense	0.08	-0.08	-0.13	-0.11	-0.33	0.02
Net Income	-3.24	-3.42	-1.27	-3.47	-21.26	-6.97
Net Income to Common	-3.24	-3.42	-1.27	-3.47	-21.26	-6.97
Shares Outstanding (Basic)	387	367	305	304	292	278
Shares Outstanding (Diluted)	387	367	305	304	292	278
Shares Change (YoY)	17.21%	20.32%	0.23%	4.26%	4.89%	-
EPS (Basic)	-0.01	-0.01	-0.00	-0.01	-0.07	-0.03
EPS (Diluted)	-0.01	-0.01	-0.00	-0.01	-0.07	-0.03
Free Cash Flow	-2.62	-3.51	-1.69	0.84	-8.42	-19.64
Free Cash Flow Per Share	-0.01	-0.01	-0.01	0.00	-0.03	-0.07
Gross Margin	41.38%	44.32%	59.97%	51.30%	-126.70%	35.66%
Operating Margin	-41.51%	-51.38%	-30.11%	-89.27%	-418.52%	-46.24%
Profit Margin	-33.88%	-40.52%	-20.72%	-85.76%	-749.98%	-60.02%
Free Cash Flow Margin	-27.36%	-41.63%	-27.61%	20.72%	-297.04%	-169.02%
EBITDA	-3.42	-3.87	-1.49	-2.98	-10.59	-4.94
EBITDA Margin	-35.73%	-45.87%	-24.29%	-73.75%	-	-42.54%
D&A For EBITDA	0.55	0.47	0.36	0.63	1.28	0.43
EBIT	-3.97	-4.33	-1.85	-3.61	-11.87	-5.37
EBIT Margin	-41.51%	-51.38%	-30.11%	-89.27%	-	-46.24%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.